Beiersdorf's medical division sales up 21%:
This article was originally published in Clinica
Executive Summary
Sales at the medical division of Beiersdorf (Germany) grew 21% to DM 1,063 million ($668 million) in the nine months ended September 30th. Excluding the effect of the acquisition of the Futuro brand from Kendall (see Clinica No 687, p 11), this represents sales growth of 8%. Total turnover rose 8% to DM 4,409 million compared with the same period in the previous year. The company forecasts sales growth of 8% for the full year.